Aerogen, an emerging specialty pharmaceutical company, is developing inhaler and nebulizer products, based on its proprietary aerosol generator technology, for the treatment of respiratory disorders in the home and hospital markets. Aerogen is also applying its technology to develop products in collaboration with pharmaceutical and biotechnology companies for the treatment of respiratory and other disorders, including diabetes. Aerogen now markets two Aeroneb nebulizer systems, one optimized for professional use in the hospital and the other for home use. Aerogen Aerodose inhaler products, in development, have advanced into Phase 2 clinical trials. Additional products are in the feasibility and pre-clinical stages of development.